While scientists don’t know a whole lot about the new Omicron variant, that isn’t stopping Pfizer from working on a new vaccine to fight the mutated virus.
Pfizer CEO Albert Bourla says the development of a new vaccine is not only underway, but he expects it to be ready in about three months.
“Friday we made our first DNA template, which is the first part of the development process of a new vaccine,” Bourla says. “We have made multiple times clear that we will be able to have the vaccine in less than 100 days.”